Drug Topics September 24, 2025
Brian Nowosielski, Rae McMahan

In part 3 of our interview with Rae McMahan, she explores her role at Prescryptive Health and how she’s helping pharmacy stakeholders navigate complex GLP-1 prescription drug benefits.

Amid the rise in popularity and constant discussions surrounding glucagon-like peptide-1 (GLP-1) medications, many stakeholders in the pharmacy industry have attempted to navigate significant complexities within this drug class. Whether it’s the patients taking them, the pharmacists dispensing them, or the pharmacy benefit managers (PBMs) determining coverage, the challenges and hurdles of GLP-1 benefits highlight a larger issue within the pharmacy industry.

“I don’t know the last time that we’ve seen a drug in market that provides this level of clinical value, where there’s not just one drug in market, there’s a...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Interview / Q&A, Pharma / Biotech, Trends
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat

Share Article